StockCIK 1628171
Revolution Medicines, Inc. (RVMD): Insider Trades and Fund Holdings
In the past 12 months, Revolution Medicines, Inc. insiders reported 0 open-market purchases worth $0 and 20 sales worth $78.0M; 20 of the sales were reported as made under a 10b5-1 trading plan.
0Insider buys, 12 months
$0Bought by insiders, 12 months
$78.0MSold by insiders, 12 months
1Tracked funds holding
Recent insider trades
Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Oct 1, 2026.
| Filed | Insider | Type | Value |
|---|---|---|---|
| Oct 1 | Alan B. SandlerChief Development Officer | ▼ SELL10b5-1 | $1.28M |
| Sep 29 | Jeff CisliniGeneral Counsel | ▼ SELL10b5-1 | $159K |
| Sep 28 | Anthony ManciniSee Remarks | ▼ SELL10b5-1 | $626K |
| Sep 28 | Anthony ManciniSee Remarks | ▼ SELL10b5-1 | $117K |
| Sep 24 | Elizabeth M. AndersonDirector | ▼ SELL10b5-1 | $1.96M |
| Sep 22 | Anthony ManciniSee Remarks | ▼ SELL10b5-1 | $347K |
| Sep 18 | Mark A. GoldsmithSee Remarks | ▼ SELL10b5-1 | $2.79M |
| Sep 18 | Stephen Michael KelseySee Remarks | ▼ SELL10b5-1 | $1.11M |
| Sep 18 | Margaret A. HornCOO | ▼ SELL10b5-1 | $990K |
| Sep 18 | Jack AndersCFO | ▼ SELL10b5-1 | $808K |
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings
All 20 RVMD insider trades →Insiders who traded in the past year
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Alan B. Sandler | Chief Development Officer | 0 | $0 | 2 | $1.34M |
| Jeff Cislini | General Counsel | 0 | $0 | 3 | $12.7M |
| Anthony Mancini | See Remarks | 0 | $0 | 5 | $4.60M |
| Elizabeth M. Anderson | Director | 0 | $0 | 1 | $1.96M |
| Mark A. Goldsmith | See Remarks | 0 | $0 | 3 | $20.8M |
| Stephen Michael Kelsey | See Remarks | 0 | $0 | 2 | $19.8M |
| Margaret A. Horn | COO | 0 | $0 | 1 | $990K |
| Jack Anders | CFO | 0 | $0 | 1 | $808K |
ADVERTISEMENT
320 × 100 ad slot
Tracked funds that report RVMD
From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.
| Fund | Shares | Value | Change |
|---|---|---|---|
| Duquesne Family Office | 399,587 | $75K | ▲ +26.5% |
| Renaissance Technologies | 0 | $0 | ▼ Sold out |
Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings
Reading these numbers
Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →